D-Ribose 5-phosphate
|
Basic information |
| Metabolite name | D-Ribose 5-phosphate |
 | HMDB0001548 |
 |
C00117 |
 |
77982 |
| Synonyms | ribose-phosphate; |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | D-Ribose 5-phosphate |
| HMDB0001548 |
|
C00117 |
|
77982 |
| Synonyms | ribose-phosphate; |
| No. of studies | 10 |
|
Relationship between D-Ribose 5-phosphate and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M076 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M076 | Type2 | CUMS + Lilium saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M076 | Type2 | CUMS + Anemarrhena saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M083 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M1041 | Type2 | pilocarpine + mitochondrial transplantation group vs. pilocarpine group | Hippocampus | C57BL/6J mouse | Up |
| Study M1090 | Type2 | CUMS + hyperbaric oxygen treatment group vs. CUMS group | Plasma | BALb/c mouse | Down |
| Study M539 | Type1 | LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Up |
| Study M671 | Type1 | CUMS group vs. control group | Striatum | Sprague-Dawley rat | Down |
| Study M828 | Type2 | ultrasonic radiation + intranasally clomipramine group vs. ultrasonic radiation group | Hippocampus | Wistar rat | Up |